Ivanov AA - Search Results

1

Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.

Zhu Y, Banerjee A, Xie P, Ivanov AA, Uddin A, Jiao Q, Chi JJ, Zeng L, Lee JY, Xue Y, Lu X, Cristofanilli M, Gradishar WJ, Henry CJ, Gillespie TW, Bhave MA, Kalinsky K, Fu H, Bahar I, Zhang B, Wan Y. Zhu Y, et al. Among authors: ivanov aa. J Clin Invest. 2024 Mar 26;134(10):e176390. doi: 10.1172/JCI176390. J Clin Invest. 2024. PMID: 38530357 Free PMC article.

2

Online informatics resources to facilitate cancer target and chemical probe discovery.

Yang X, Fu H, Ivanov AA. Yang X, et al. Among authors: ivanov aa. RSC Med Chem. 2020 Apr 9;11(6):611-624. doi: 10.1039/d0md00012d. eCollection 2020 Jun 1. RSC Med Chem. 2020. PMID: 33479663 Free PMC article. Review.

3

High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.

Yang X, Amgad M, Cooper LAD, Du Y, Fu H, Ivanov AA. Yang X, et al. Among authors: ivanov aa. J Transl Med. 2020 Sep 1;18(1):334. doi: 10.1186/s12967-020-02502-w. J Transl Med. 2020. PMID: 32873298 Free PMC article.

4

NSD3S stabilizes MYC through hindering its interaction with FBXW7.

Gonzalez-Pecchi V, Kwan AK, Doyle S, Ivanov AA, Du Y, Fu H. Gonzalez-Pecchi V, et al. Among authors: ivanov aa. J Mol Cell Biol. 2020 Jul 3;12(6):438-447. doi: 10.1093/jmcb/mjz098. J Mol Cell Biol. 2020. PMID: 31638140 Free PMC article.

5

Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.

Yang X, Fan D, Troha AH, Ahn HM, Qian K, Liang B, Du Y, Fu H, Ivanov AA. Yang X, et al. Among authors: ivanov aa. Bioorg Med Chem. 2021 Sep 1;45:116324. doi: 10.1016/j.bmc.2021.116324. Epub 2021 Jul 22. Bioorg Med Chem. 2021. PMID: 34333394 Free PMC article.

6

Hypomorph mutation-directed small-molecule protein-protein interaction inducers to restore mutant SMAD4-suppressed TGF-β signaling.

Tang C, Mo X, Niu Q, Wahafu A, Yang X, Qui M, Ivanov AA, Du Y, Fu H. Tang C, et al. Among authors: ivanov aa. Cell Chem Biol. 2021 May 20;28(5):636-647.e5. doi: 10.1016/j.chembiol.2020.11.010. Epub 2020 Dec 15. Cell Chem Biol. 2021. PMID: 33326750 Free PMC article.

7

Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.

Xiong J, Pecchi VG, Qui M, Ivanov AA, Mo X, Niu Q, Chen X, Fu H, Du Y. Xiong J, et al. Among authors: ivanov aa. Assay Drug Dev Technol. 2018 Feb/Mar;16(2):96-106. doi: 10.1089/adt.2017.835. Assay Drug Dev Technol. 2018. PMID: 29634317 Free PMC article.

8

TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS.

Cicka D, Niu Q, Qui M, Qian K, Miller E, Fan D, Mo X, Ivanov AA, Sarafianos SG, Du Y, Fu H. Cicka D, et al. Among authors: ivanov aa. J Mol Cell Biol. 2023 Aug 3;15(3):mjad017. doi: 10.1093/jmcb/mjad017. J Mol Cell Biol. 2023. PMID: 36921991 Free PMC article.

9

Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells.

Shu C, Zheng X, Wuhafu A, Cicka D, Doyle S, Niu Q, Fan D, Qian K, Ivanov AA, Du Y, Mo X, Fu H. Shu C, et al. Among authors: ivanov aa. Acta Pharmacol Sin. 2022 Sep;43(9):2419-2428. doi: 10.1038/s41401-021-00847-6. Epub 2022 Jan 14. Acta Pharmacol Sin. 2022. PMID: 35031699 Free PMC article.

10

OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.

Ivanov AA, Gonzalez-Pecchi V, Khuri LF, Niu Q, Wang Y, Xu Y, Bai Y, Mo X, Prochownik EV, Johns MA, Du Y, Khuri FR, Fu H. Ivanov AA, et al. Oncogene. 2017 Oct 19;36(42):5852-5860. doi: 10.1038/onc.2017.180. Epub 2017 Jun 19. Oncogene. 2017. PMID: 28628118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page